Obulytix
The computed 12-month bankruptcy probability of Obulytix is 1.8% (moderate). The 2024 annual accounts show equity of €3.82M and a net result of €-1.08M. Its solvency ranks better than 70% of 46 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €3.82M |
| Net result | €-1.08M |
| Staff (FTE) | 2.6 |
| Better than sector | 70% |
Mixed profile: strong on solvency, weaker on profitability.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 74.9% | 46.9% | |
| Net result | €-1.08M | €-1k | |
| Equity | €3.82M | €108k | |
| Gross operating margin | €-590k | €28k | |
| Total assets | €5.10M | €284k |
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €-843k |
| Net profit | €-1.08M |
| Cash flow | €-827k |
| Staff costs | €253k |
| Income taxes | - |
| Dividends | - |
| Total assets | €5.10M |
| Equity | €3.82M |
| Debt | €1.28M |
| of which ≤ 1y | €342k |
| of which > 1y | - |
| Working capital | €2.74M |
| Employees (FTE) | 2.6 |
| 2024 | |
|---|---|
| Current ratio | 9.00 |
| Quick ratio | 9.00 |
| Working capital ratio | 53.6% |
| Solvency | 74.9% |
| Debt / equity | 0.34 |
| Long-term debt ratio | - |
| Interest coverage | -712.21 |
| Gross margin | - |
| Net margin | - |
| ROA | -21.2% |
| ROE | -28.3% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €5.10M |
| Fixed assets | 21/28 | €1.97M |
| Formation expenses | 20 | €51k |
| Intangible fixed assets | 21 | €1.75M |
| Tangible fixed assets | 22/27 | €222k |
| Current assets | 29/58 | €3.08M |
| Amounts receivable within one year | 40/41 | €580k |
| Cash & bank | 54/58 | €1.51M |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €5.10M |
| Equity | 10/15 | €3.82M |
| Contributions / capital | 10/11 | €4.67M |
| Accumulated profits (losses) | 14 | €-1.08M |
| Amounts payable | 17/49 | €1.28M |
| Amounts payable within one year | 42/48 | €342k |
| Trade debts payable within one year | 44 | €315k |
| Income statement | ||
| Gross operating margin | 9900 | €-590k |
| Operating result | 9901 | €-1.10M |
| Financial income | 75 | €17k |
| Financial charges | 65 | €1k |
| Result before taxes | 9903 | €-1.08M |
| Net result for the period | 9904 | €-1.08M |
| Result to be appropriated | 9905 | €-1.08M |
-
Current01-10-2025 → present
-
Current14-07-2025 → present
Former directors (2)
-
Former- → 01-10-2025
-
Former- → 01-08-2024
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISESCurrent Statutory auditor · represented by Kevin Defauw |
- | 02-07-2024 → present |
| NACE primary | Vervaardiging van geneesmiddelen(21201) |
| Legal form | Private limited company(610) |
| Incorporation | 29-06-2023 |
| Status | Active |
| Postal code | 9052 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44082B0667/00A000 | Flanders | 6,161 m² | 1 · 1,560 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
19-12-2025 1 director appointed, 1 resigning
- Philipp Mueller, Bestuurder
- Niklas Czeloth, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Niklas Czeloth",
"address": null,
"birth_date": null
},
"effective_date": "2025-10-01",
"evidence_quote": "De algemene vergadering heeft kennis genomen van het ontslag van Niklas Czeloth, met ingang vanaf 1 oktober 2025, van zijn functie als bestuurder van de Vennootschap overeenkomstig artikel 6.2(e) van de aandeelhoudersovereenkomst betreffende de Vennootschap dd. 26 juli 2023 (de \u0022Aandeelhoudersoveree"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philipp Mueller",
"address": null,
"birth_date": null
},
"effective_date": "2025-10-01",
"evidence_quote": "De algemene vergadering heeft besloten, met ingang vanaf 1 oktober 2025, de heer Philipp Mueller te benoemen als bestuurder van de Vennootschap overeenkomstig artikel 6.2(e) van de Aandeelhoudersovereenkomst."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0803.351.624",
"name_full": "OBULYTIX",
"legal_form": "BV"
}
}10-11-2025 Capital increase of €1,000,944.19
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 1000944.19,
"currency": "EUR",
"after_eur": null,
"delta_eur": 1000944.19,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-11-04",
"evidence_quote": "Het beschikbaar eigen vermogen werd verhoogd met 1.000.944,19 EUR. Voormelde bijkomende inbreng gaat gepaard met het cre\u00EBren van 14.831 nieuwe soort B aandelen... Er werd in geld ingeschreven op 14.831 nieuwe aandelen, tegen de uitoefenprijs van 67,49 EUR... Op ieder aandeel werd gestort ten belope van 100%, hetzij in totaal 67,49 EUR per aandeel",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0803.351.624",
"name_full": "OBULYTIX",
"legal_form": "BV"
}
}27-10-2025 Registered office moved from Kampenhout to Gent
- Laarstraat 37, 1910 Kampenhout → Suzanne Tassierstraat 1, 9052 Gent
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Gent",
"region": "Vlaams Gewest",
"street": "Suzanne Tassierstraat",
"country": "BE",
"postcode": "9052",
"box_number": "unit 3.4",
"street_number": "1"
},
"old_address": {
"city": "Kampenhout",
"region": "Vlaams Gewest",
"street": "Laarstraat",
"country": "BE",
"postcode": "1910",
"box_number": null,
"street_number": "37"
},
"effective_date": "2025-07-07",
"evidence_quote": "BESLOTEN met ingang vanaf de datum van deze besluiten de zetel van de Vennootschap te verplaatsen van Laarstraat 37, 1910 Kampenhout (Belgi\u00EB) naar Suzanne Tassierstraat 1 (unit 3.4), 9052 Gent (Belgi\u00EB)."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0803.351.624",
"name_full": "OBULYTIX",
"legal_form": "BV"
}
}01-10-2024 2 directors appointed, 1 resigning
- Kristof Van Emelen, Bestuurder
- Kristof Van Emelen, Gedelegeerd bestuurder
- Margit Sonja Reingruber, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Kristof Van Emelen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0803351624",
"name": "Biotilia BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-08-01",
"evidence_quote": "BESLOTEN, Biotilia BV, vast vertegenwoordigd door haar bestuurder, Kristof Van Emelen, te benoemen tot bestuurder van de Vennootschap, met ingang vanaf 1 augustus 2024"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Kristof Van Emelen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0803351624",
"name": "Biotilia BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-08-01",
"evidence_quote": "BESLOTEN om Biotilia BV, vast vertegenwoordigd door haar bestuurder, Kristof Van Emelen, met zetel te Prinses Josephine Charlottelaan 78, 9100 Sint-Niklaas (Belgi\u00EB), met ingang vanaf 1 augustus 2024 en voor de duurtijd van zijn mandaat als bestuurder van de Vennootschap (met inbegrip van eventuele h"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Margit Sonja Reingruber",
"address": null,
"birth_date": null
},
"effective_date": "2024-08-01",
"evidence_quote": "BESLOTEN om kennis te nemen van het ontslag van mevrouw Margit Sonja Reingruber als bestuurder van de Vennootschap, en dit met ingang vanaf 1 augustus 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0803.351.624",
"name_full": "OBULYTIX",
"legal_form": "BV"
}
}02-07-2024 Kevin Defauw appointed as statutory auditor
- Kevin Defauw, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Kevin Defauw",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0431088289",
"name": "BDO Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Op voorstel van het bestuursorgaan, besluit de bijzondere algemene vergadering te benoemen als commissaris van de onderneming voor een periode van drie jaar, tot aan de jaarvergadering te houden in 2027: BDO Bedrijfsrevisoren BV, met zetel te 1930 Zaventem, Da Vincilaan 9 Box E.6, RPR Brussel (Neder"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0803.351.624",
"name_full": "OBULYTIX",
"legal_form": "BV"
}
}05-03-2024 Publication in the Belgian Official Gazette, Minor change
Technical details
{
"notary": {
"name": "Yorik DESMYTTERE",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-03-05",
"filing_date": "2024-03-01",
"act_kind_objet": "BENAMING, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2024-02-07",
"unanimous": null
},
"agm_change": {
"new_schedule": null,
"old_schedule": null,
"effective_from_year": 2024,
"rule_changes_summary": "Wijziging van artikel 1 van de statuten, met name de rechtsvorm en de naam van de vennootschap."
},
"detected_kind": "agm_rules_change",
"other_address": null,
"mandate_renewal": null,
"subject_company": {
"kbo": "0803.351.624",
"name_full": "ComBioNX",
"legal_form": "BV"
},
"accounts_deposit": null,
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"een verslag van het bestuursorgaan opgesteld in toepassing van artikel 5:122, eerste lid van het Wetboek van vennootschappen en verenigingen",
"een verslag van het bestuursorgaan opgesteld in toepassing van artikel 5:102, tweede lid van het Wetboek van vennootschappen en verenigingen",
"een verslag van een bedrijfsrevisor opgesteld in toepassing van artikel 5:102, tweede lid van het Wetboek van vennootschappen en verenigingen",
"een inschrijvingsrechtenplan",
"de geco\u00F6rdineerde tekst van statuten"
],
"fiscal_year_change": null,
"liquidation_closure": null,
"officer_designation": null,
"special_procuration": null,
"is_volet_a_only_stub": false,
"vakbekwaamheid_change": null,
"should_reroute_to_category": null,
"single_shareholder_declaration": null
}07-08-2023 Capital increase of €2,998,918.15
- 3 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 1649725.56,
"currency": "EUR",
"after_eur": null,
"delta_eur": 1649725.56,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-07-26",
"evidence_quote": "De vergadering beslist het eigen vermogen te verhogen ten belope van 1.649.725,56 EUR, door een inbreng in natura en door de uitgifte van 24.444 Soort A Aandelen",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 2998918.15,
"currency": "EUR",
"after_eur": null,
"delta_eur": 2998918.15,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-07-26",
"evidence_quote": "De vergadering beslist het eigen vermogen te verhogen ten belope van 2.998.918,15 EUR, en beslist dat deze bijkomende inbreng zal verwezenlijkt worden door een inbreng in geld",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 1500000.0,
"currency": "EUR",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2023-07-26",
"evidence_quote": "De vergadering beslist het eigen vermogen te verhogen ten belope van maximaal 1.500.000,00 EUR, en beslist dat deze bijkomende inbreng zal verwezenlijkt worden door een inbreng in geld",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0803.351.624",
"name_full": "COMBIONX",
"legal_form": "BV"
}
}03-07-2023 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "1910 Kampenhout, Laarstraat 37",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1981-07-02",
"name": "BRIERS Yves",
"niss": null,
"address": "1910 Kampenhout, Laarstraat 37"
},
"share_class": "naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 5000,
"holder_person_name": "BRIERS Yves",
"is_subscriber_only": false,
"n_shares_subscribed": 5000,
"amount_subscribed_eur": 5000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1994-06-07",
"name": "CRIEL Bjorn",
"niss": null,
"address": "2140 Antwerpen (Borgerhout), Bouwhandelstraat 26"
},
"share_class": "naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 5000,
"holder_person_name": "CRIEL Bjorn",
"is_subscriber_only": false,
"n_shares_subscribed": 5000,
"amount_subscribed_eur": 5000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1991-04-03",
"name": "GRIMON Dennis",
"niss": null,
"address": "9000 Gent, Hamerstraat 76"
},
"share_class": "naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 5000,
"holder_person_name": "GRIMON Dennis",
"is_subscriber_only": false,
"n_shares_subscribed": 5000,
"amount_subscribed_eur": 5000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1989-03-05",
"name": "CARVALHO MAURICIO DA FONSECA Maria Joao",
"niss": null,
"address": "9000 Gent, Londenstraat 46 bus 0202"
},
"share_class": "naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 5000,
"holder_person_name": "CARVALHO MAURICIO DA FONSECA Maria Joao",
"is_subscriber_only": false,
"n_shares_subscribed": 5000,
"amount_subscribed_eur": 5000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 20000,
"subject_company": {
"kbo": "0803.351.624",
"name_full": "ComBioNX",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2023-06-28",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Obulytix |